MyndTec Inc

MyndTec Inc. is a medical technology company specializing in neurotechnology products and AI-powered software solutions for treating neurological disorders, chronic pain, and central nervous system injuries including stroke and spinal cord injuries. The company's primary offering, MyndMove™, is a non-invasive neuromodulation therapy that uses electrical stimulation to trigger neuroplasticity, enabling patients with paralysis to regain movement and function. MyndLink™, an AI-powered clinical decision support platform, predicts treatment outcomes, optimizes protocols, and automates clinical workflows to improve patient recovery while reducing healthcare costs. MyndTec integrates advanced machine learning and predictive analytics to address critical gaps in neurological care, particularly the 60-70% of stroke survivors experiencing persistent upper limb impairment and the 30% failure rate of spinal cord stimulator procedures. The company is also developing regenerative therapies utilizing neural stem cells for brain tissue repair. Both products are authorized in the U.S. and Canada, targeting rehabilitation facilities and neurological care centers seeking evidence-based, outcome-optimized treatment solutions.